They announced positive top line results from their P3 trial. Adolescent and paediatric trials are happening both this month and next. Major competitors such as NYSE:JNJ, NYSE:PFE, NYSE:NVS that require multiple pills a day for the same effect. Extremely large TAM. Buyout candidate? We have popped off of the bottom channel and are looking for 1.10. A breakout above that sends it to 1.40-1.50 range. This is my own opinion and shouldn't be taken as financial advice. Own your trades.